ResMed (RMD)
(Delayed Data from NYSE)
$216.59 USD
+2.40 (1.12%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $216.63 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 141 - 160 ( 532 total )
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Now Building an International SAAS Business
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for RMD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Supply Chain Constraints Remain Frustrating
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
PHG Remediation Timeline Again Extended
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for RMD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department